25 research outputs found
MCT1 in Invasive Ductal Carcinoma: Monocarboxylate Metabolism and Aggressive Breast Cancer.
Introduction: Monocarboxylate transporter 1 (MCT1) is an importer of monocarboxylates such as lactate and pyruvate and a marker of mitochondrial metabolism. MCT1 is highly expressed in a subgroup of cancer cells to allow for catabolite uptake from the tumor microenvironment to support mitochondrial metabolism. We studied the protein expression of MCT1 in a broad group of breast invasive ductal carcinoma specimens to determine its association with breast cancer subtypes and outcomes. Methods: MCT1 expression was evaluated by immunohistochemistry on tissue micro-arrays (TMA) obtained through our tumor bank. Two hundred and fifty-seven cases were analyzed: 180 cases were estrogen receptor and/or progesterone receptor positive (ER+ and/or PR+), 62 cases were human epidermal growth factor receptor 2 positive (HER2+), and 56 cases were triple negative breast cancers (TNBC). MCT1 expression was quantified by digital pathology with Aperio software. The intensity of the staining was measured on a continuous scale (0-black to 255-bright white) using a co-localization algorithm. Statistical analysis was performed using a linear mixed model. Results: High MCT1 expression was more commonly found in TNBC compared to ER+ and/or PR+ and compared to HER-2+ (p \u3c 0.001). Tumors with an in-situ component were less likely to stain strongly for MCT1 (p \u3c 0.05). High nuclear grade was associated with higher MCT1 staining (p \u3c 0.01). Higher T stage tumors were noted to have a higher expression of MCT1 (p \u3c 0.05). High MCT1 staining in cancer cells was associated with shorter progression free survival, increased risk of recurrence, and larger size independent of TNBC status (p \u3c 0.05). Conclusion: MCT1 expression, which is a marker of high catabolite uptake and mitochondrial metabolism, is associated with recurrence in breast invasive ductal carcinoma. MCT1 expression as quantified with digital image analysis may be useful as a prognostic biomarker and to design clinical trials using MCT1 inhibitors
TP53-inducible Glycolysis and Apoptosis Regulator (TIGAR) Metabolically Reprograms Carcinoma and Stromal Cells in Breast Cancer.
A subgroup of breast cancers has several metabolic compartments. The mechanisms by which metabolic compartmentalization develop in tumors are poorly characterized. TP53 inducible glycolysis and apoptosis regulator (TIGAR) is a bisphosphatase that reduces glycolysis and is highly expressed in carcinoma cells in the majority of human breast cancers. Hence we set out to determine the effects of TIGAR expression on breast carcinoma and fibroblast glycolytic phenotype and tumor growth. The overexpression of this bisphosphatase in carcinoma cells induces expression of enzymes and transporters involved in the catabolism of lactate and glutamine. Carcinoma cells overexpressing TIGAR have higher oxygen consumption rates and ATP levels when exposed to glutamine, lactate, or the combination of glutamine and lactate. Coculture of TIGAR overexpressing carcinoma cells and fibroblasts compared with control cocultures induce more pronounced glycolytic differences between carcinoma and fibroblast cells. Carcinoma cells overexpressing TIGAR have reduced glucose uptake and lactate production. Conversely, fibroblasts in coculture with TIGAR overexpressing carcinoma cells induce HIF (hypoxia-inducible factor) activation with increased glucose uptake, increased 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 (PFKFB3), and lactate dehydrogenase-A expression. We also studied the effect of this enzyme on tumor growth. TIGAR overexpression in carcinoma cells increases tumor growth in vivo with increased proliferation rates. However, a catalytically inactive variant of TIGAR did not induce tumor growth. Therefore, TIGAR expression in breast carcinoma cells promotes metabolic compartmentalization and tumor growth with a mitochondrial metabolic phenotype with lactate and glutamine catabolism. Targeting TIGAR warrants consideration as a potential therapy for breast cancer
TP53-inducible Glycolysis and Apoptosis Regulator (TIGAR) Metabolically Reprograms Carcinoma and Stromal Cells in Breast Cancer
A subgroup of breast cancers has several metabolic compartments. The mechanisms by which metabolic compartmentalization develop in tumors are poorly characterized. TP53 inducible glycolysis and apoptosis regulator (TIGAR) is a bisphosphatase that reduces glycolysis and is highly expressed in carcinoma cells in the majority of human breast cancers. Hence we set out to determine the effects of TIGAR expression on breast carcinoma and fibroblast glycolytic phenotype and tumor growth. The overexpression of this bisphosphatase in carcinoma cells induces expression of enzymes and transporters involved in the catabolism of lactate and glutamine. Carcinoma cells overexpressing TIGAR have higher oxygen consumption rates and ATP levels when exposed to glutamine, lactate, or the combination of glutamine and lactate. Coculture of TIGAR overexpressing carcinoma cells and fibroblasts compared with control cocultures induce more pronounced glycolytic differences between carcinoma and fibroblast cells. Carcinoma cells overexpressing TIGAR have reduced glucose uptake and lactate production. Conversely, fibroblasts in coculture with TIGAR overexpressing carcinoma cells induce HIF (hypoxia-inducible factor) activation with increased glucose uptake, increased 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 (PFKFB3), and lactate dehydrogenase-A expression. We also studied the effect of this enzyme on tumor growth. TIGAR overexpression in carcinoma cells increases tumor growth in vivo with increased proliferation rates. However, a catalytically inactive variant of TIGAR did not induce tumor growth. Therefore, TIGAR expression in breast carcinoma cells promotes metabolic compartmentalization and tumor growth with a mitochondrial metabolic phenotype with lactate and glutamine catabolism. Targeting TIGAR warrants consideration as a potential therapy for breast cancer
Macrophage and adipocyte interaction as a source of inflammation in kidney disease
In obesity, adipose tissue derived inflammation is associated with unfavorable metabolic consequences. Uremic inflammation is prevalent and contributes to detrimental outcomes. However, the contribution of adipose tissue inflammation in uremia has not been characterized. We studied the contribution of adipose tissue to uremic inflammation in-vitro, in-vivo and in human samples. Exposure to uremic serum resulted in activation of inflammatory pathways including NFÎșB and HIF1, upregulation of inflammatory cytokines/chemokines and catabolism with lipolysis, and lactate production. Also, co-culture of adipocytes with macrophages primed by uremic serum resulted in higher inflammatory cytokine expression than adipocytes exposed only to uremic serum. Adipose tissue of end stage renal disease subjects revealed increased macrophage infiltration compared to controls after BMI stratification. Similarly, mice with kidney disease recapitulated the inflammatory state observed in uremic patients and additionally demonstrated increased peripheral monocytes and inflammatory polarization of adipose tissue macrophages (ATMS). In contrast, adipose tissue in uremic IL-6 knock out mice showed reduced ATMS density compared to uremic wild-type controls. Differences in ATMS density highlight the necessary role of IL-6 in macrophage infiltration in uremia. Uremia promotes changes in adipocytes and macrophages enhancing production of inflammatory cytokines. We demonstrate an interaction between uremic activated macrophages and adipose tissue that augments inflammation in uremia
Effect of the haematocrit layer geometry on Plasmodium falciparum static thin-layer in vitro cultures
<p>Abstract</p> <p>Background</p> <p><it>In vitro </it>cultivation of <it>Plasmodium falciparum </it>is usually carried out through the continuous preservation of infected erythrocytes deposited in static thin layers of settled haematocrit. This technique, called the candle-jar method, was first achieved by Trager and Jensen in 1976 and has undergone slight modifications since then. However, no systematic studies concerning the geometry of the haematocrit layer have been carried out. In this work, a thorough investigation of the effects of the geometric culturing conditions on the parasite's development is presented.</p> <p>Methods</p> <p>Several experimental trials exploring different settings have been carried out, covering haematocrit layer depths that ranged from 6 mm to 3 mm and separation between the walls of the culturing device that ranged from 7.5 mm to 9 mm. The obtained results have been analysed and compared to different system-level models and to an Individual-Based Model.</p> <p>Conclusion</p> <p>In line with the results, a mechanism governing the propagation of the infection which limits it to the vicinity of the interface between the haematocrit layer and the culture medium is deduced, and the most appropriate configurations are proposed for further experimental assays.</p
Metabolic Compartmentalization as a Driver of Head and Neck Squamous Cell Carcinoma Aggressiveness
Head and neck squamous cell carcinoma (HNSCC) is the 7th leading cancer worldwide with 470,000 deaths per year. Cigarette smoking is the main cause of the disease. Standard of care treatment includes surgery, radiotherapy, and chemotherapy, and is associated with high comorbidities and emergence of recurrences. There is a lack of effective targeted therapies in HNSCC, and recently approved immunotherapy fails in 80% of patients. The 5-year survival rate for HNSCC is around 65%, however it has not markedly improved in the recent decades. Therefore, further characterization of the drivers of HNSCC progression is needed to develop novel treatment strategies and improve patient outcomes. This thesis focuses on studying targetable metabolic dependencies in HNSCC. In 2013, our group discovered that two metabolically distinct compartments co-exist in HNSCC and that this is associated with tumor aggressiveness. The tumor stroma, mainly composed of cancer-associated fibroblasts (CAFs), is highly glycolytic and provides nutrients to adjacent proliferating cancer cells with high mitochondrial oxidative metabolism (OXPHOS). Loss of caveolin-1 (CAV1) and upregulation of the monocarboxylate transporter 4 (MCT4) are markers of glycolytic metabolism and metabolite secretion in CAFs. Upregulation of MCT1 and the translocase of the outer mitochondrial membrane 20 (TOMM20) are markers of metabolite uptake and OXPHOS metabolism in cancer cells. The research presented hereby provides evidence that altering metabolic compartmentalization could be an efficient anti-cancer strategy in HNSCC. Using experimental models that reproduce human HNSCC metabolism, we have pharmacologically, chemically, and genetically manipulated metabolic compartmentalization and determined the effects on cancer cell aggressiveness, tumor growth and inflammation. Pharmacological intervention using the anti-OXPHOS drug metformin impaired tumor growth while inducing apoptosis and decreasing MCT1 in cancer cells, an effect that was dependent on the ability to upregulate CAV1 in fibroblasts. Chemical manipulation by cigarette smoke exposure induced glycolysis and MCT4 expression in fibroblasts, and these reprogrammed fibroblasts promoted metabolic compartmentalization, cancer cell aggressiveness, tumor growth and inflammation. Finally, genetic manipulation of fibroblast MCT4 determined that upregulation of MCT4 in fibroblasts is a driver of HNSCC aggressiveness. Altogether, our work has demonstrated that the metabolic cooperation between CAFs and cancer cells has a major influence in HNSCC progression and is a potentially targetable vulnerability in HNSCC
Monocarboxylate Transporter 4 in Cancer-Associated Fibroblasts Is a Driver of Aggressiveness in Aerodigestive Tract Cancers
The most common cancers of the aerodigestive tract (ADT) are non-small cell lung cancer (NSCLC) and head and neck squamous cell carcinoma (HNSCC). The tumor stroma plays an important role in ADT cancer development and progression, and contributes to the metabolic heterogeneity of tumors. Cancer-associated fibroblasts (CAFs) are the most abundant cell type in the tumor stroma of ADT cancers and exert pro-tumorigenic functions. Metabolically, glycolytic CAFs support the energy needs of oxidative (OXPHOS) carcinoma cells. Upregulation of the monocarboxylate transporter 4 (MCT4) and downregulation of isocitrate dehydrogenase 3α (IDH3α) are markers of glycolysis in CAFs, and upregulation of the monocarboxylate transporter 1 (MCT1) and the translocase of the outer mitochondrial membrane 20 (TOMM20) are markers of OXPHOS in carcinoma cells. It is unknown if glycolytic metabolism in CAFs is a driver of ADT cancer aggressiveness. In this study, co-cultures in vitro and co-injections in mice of ADT carcinoma cells with fibroblasts were used as experimental models to study the effects of fibroblasts on metabolic compartmentalization, oxidative stress, carcinoma cell proliferation and apoptosis, and overall tumor growth. Glycolytic metabolism in fibroblasts was modulated using the HIF-1α inhibitor BAY 87-2243, the antioxidant N-acetyl cysteine, and genetic depletion of MCT4. We found that ADT human tumors express markers of metabolic compartmentalization and that co-culture models of ADT cancers recapitulate human metabolic compartmentalization, have high levels of oxidative stress, and promote carcinoma cell proliferation and survival. In these models, BAY 87-2243 rescues IDH3α expression and NAC reduces MCT4 expression in fibroblasts, and these treatments decrease ADT carcinoma cell proliferation and increase cell death. Genetic depletion of fibroblast MCT4 decreases proliferation and survival of ADT carcinoma cells in co-culture. Moreover, co-injection of ADT carcinoma cells with fibroblasts lacking MCT4 reduces tumor growth and decreases the expression of markers of metabolic compartmentalization in tumors. In conclusion, metabolic compartmentalization with high expression of MCT4 in CAFs drives aggressiveness in ADT cancers
Mitochondrial and glycolytic metabolic compartmentalization in diffuse large B-cell lymphoma.
Metabolic heterogeneity between neoplastic cells and surrounding stroma has been described in several epithelial malignancies; however, the metabolic phenotypes of neoplastic lymphocytes and neighboring stroma in diffuse large B-cell lymphoma (DLBCL) is unknown. We investigated the metabolic phenotypes of human DLBCL tumors by using immunohistochemical markers of glycolytic and mitochondrial oxidative phosphorylation (OXPHOS) metabolism. The lactate importer MCT4 is a marker of glycolysis, whereas the lactate importer MCT1 and TOMM20 are markers of OXPHOS metabolism. Staining patterns were assessed in 33 DLBCL samples as well as 18 control samples (non-neoplastic lymph nodes). TOMM20 and MCT1 were highly expressed in neoplastic lymphocytes, indicating an OXPHOS phenotype, whereas non-neoplastic lymphocytes in the control samples did not express these markers. Stromal cells in DLBCL samples strongly expressed MCT4, displaying a glycolytic phenotype, a feature not seen in stromal elements of non-neoplastic lymphatic tissue. Furthermore, the differential expression of lactate exporters (MCT4) on tumor-associated stroma and lactate importers (MCT1) on neoplastic lymphocytes support the hypothesis that neoplastic cells are metabolically linked to the stroma likely via mutually beneficial reprogramming. MCT4 is a marker of tumor-associated stroma in neoplastic tissue. Our findings suggest that disruption of neoplastic-stromal cell metabolic heterogeneity including MCT1 and MCT4 blockade should be studied to determine if it could represent a novel treatment target in DLBCL
MCT1 in Invasive Ductal Carcinoma: Monocarboxylate Metabolism and Aggressive Breast Cancer.
Anthropogenic infection of domestic cats with SARS-CoV-2 alpha variant B.1.1.7 lineage in Buenos Aires
SARS-CoV-2 reverse zoonosis, particularly to domestic animals, and the potential role of infected animals in perpetuating the spread of the virus is an issue of increasing concern. In this case report, we identified the natural infection of two cats by SARS-CoV-2, in Argentina, whose owner had been previously infected by SARS-CoV-2. Viral genetic material was detected in feline oropharyngeal (OP) and rectal (R) swab by RT-qPCR, and sequence analysis revealed that the virus infecting the owner and one cat were genetically similar. The alpha variant (B.1.1.7 lineage) was identified with a unique additional mutation, strongly suggesting human-to-cat route of transmission. This study reinforces the One Health concept and the importance of integrating human, animal, and environmental perspectives to promptly address relevant health issues.Instituto de VirologĂaFil: Pecora, Andrea. Instituto Nacional de TecnologĂa Agropecuaria (INTA). Instituto de VirologĂa e Innovaciones TecnolĂłgicas; ArgentinaFil: Pecora, Andrea. Consejo Nacional de Investigaciones CientĂficas y TĂ©cnicas; ArgentinaFil: Malacari, DarĂo Amilcar. Diagnogen S.A.; ArgentinaFil: Mozgovoj, Marina Valeria. Universidad Nacional de Hurlingham. Instituto de BiotecnologĂa; ArgentinaFil: Mozgovoj, Marina Valeria. Centro de Agroindustria. Instituto de Ciencia y TecnologĂa de Sistemas Alimentarios Sustentables; ArgentinaFil: Mozgovoj, Marina Valeria. Consejo Nacional de Investigaciones CientĂficas y TĂ©cnicas; ArgentinaFil: DĂaz, MarĂa de los Ăngeles. Ministerio de Salud. SecretarĂa de Salud de la Municipalidad de la Matanza; ArgentinaFil: Peralta, Andrea Veronica. Instituto Nacional de TecnologĂa Agropecuaria (INTA). Instituto de AgrobiotecnologĂa y BiologĂa Molecular; ArgentinaFil: Peralta, Andrea Veronica. Consejo Nacional de Investigaciones CientĂficas y TĂ©cnicas; ArgentinaFil: Cacciabue, Marco Polo Domingo. Instituto Nacional de TecnologĂa Agropecuaria (INTA). Instituto de AgrobiotecnologĂa y BiologĂa Molecular; ArgentinaFil: Cacciabue, Marco Polo Domingo. Consejo Nacional de Investigaciones CientĂficas y TĂ©cnicas; ArgentinaFil: Puebla, Andrea Fabiana. Instituto Nacional de TecnologĂa Agropecuaria (INTA). Instituto de AgrobiotecnologĂa y BiologĂa Molecular; ArgentinaFil: Puebla, Andrea Fabiana. Consejo Nacional de Investigaciones CientĂficas y TĂ©cnicas; ArgentinaFil: Carusso, Cristian. Universidad de Buenos Aires. Facultad de Ciencias Veterinarias; ArgentinaFil: Mundo, Silvia Leonor. Universidad de Buenos Aires. Facultad de Ciencias Veterinarias; ArgentinaFil: Gonzalez Lopez Ledesma, MarĂa Mora. FundaciĂłn Instituto Leloir. Instituto de Investigaciones BioquĂmicas de Buenos Aires; ArgentinaFil: Gonzalez Lopez Ledesma, MarĂa Mora. Consejo Nacional de Investigaciones CientĂficas y TĂ©cnicas; ArgentinaFil: Gamarnik, Andrea Vanesa. FundaciĂłn Instituto Leloir. Instituto de Investigaciones BioquĂmicas de Buenos Aires; ArgentinaFil: Gamarnik, Andrea Vanesa. Consejo Nacional de Investigaciones CientĂficas y TĂ©cnicas; ArgentinaFil: Rinaldi, Osvaldo. Veterinaria Rinaldi Vidal; ArgentinaFil: Vidal, Osvaldo. Veterinaria Rinaldi Vidal; ArgentinaFil: Mas, Javier. Diagnogen SA; ArgentinaFil: Mas, Javier. Diagnotest SRL; ArgentinaFil: Dus Santos, Maria Jose. Instituto Nacional de TecnologĂa Agropecuaria (INTA). Instituto de VirologĂa e Innovaciones TecnolĂłgicas; ArgentinaFil: Dus Santos, Maria Jose. Universidad Nacional de Hurlingham. Instituto de BiotecnologĂa; Argentin